Carnegie Investment Counsel’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-93,334
Closed -$3.03M 576
2025
Q4
$3.03M Sell
93,334
-210,575
-69% -$9.02M 0.06% 228
2025
Q3
$17.2M Buy
303,909
+61,560
+25% +$3.15M 0.32% 89
2025
Q2
$12.1M Sell
242,349
-217,925
-47% -$9.85M 0.24% 118
2025
Q1
$12.8M Buy
460,274
+83,364
+22% +$3.1M 0.3% 102
2024
Q4
$9.11M Buy
376,910
+76,650
+26% +$1.9M 0.26% 101
2024
Q3
$5.53M Buy
+300,260
New +$5.38M 0.16% 138

Other funds holding HIMS

Carnegie Investment Counsel's HIMS Position: Q1 2026 in Review

Carnegie Investment Counsel sold out of Hims & Hers Health (HIMS) in Q1 2026, closing a stake of 93,334 shares — an estimated $3.03M sold.

Carnegie Investment Counsel first reported a position in HIMS in Q3 2024 and held it in 6 quarters. The position peaked at $17.2M in Q3 2025. 434 funds tracked by Wall St. Rank hold HIMS as of Q1 2026.

  • Carnegie Investment Counsel reported no remaining Hims & Hers Health position as of Q1 2026 after selling out during the quarter.
  • Carnegie Investment Counsel sold 93,334 Hims & Hers Health shares in Q1 2026, an estimated $3.03M.
  • Carnegie Investment Counsel first reported a position in Hims & Hers Health in Q3 2024 and held it in 6 quarters.
  • Carnegie Investment Counsel's Hims & Hers Health position peaked at $17.2M in Q3 2025.
  • 434 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2026.

Based on Carnegie Investment Counsel's 13F filing for Q1 2026, filed 1 May 2026.